• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,166
2,283
1,853
1,828
1,712

COUNTRY

871
643
263
249
208

CATEGORIES

  • 856
  • 184
  • 950
  • 1,126
    • 99
  • 385
  • 270
  • 252
  • 65
  • 379
  • 673
  • 1,276
  • 1,621
  • 625
  • 883
  • 1,674
  • 2,641
    • 574
    • 118
    • 550
    • 75
    • 526
    • 43
    • 505
    • 18
    • 18
    • 23
  • 505
  • 726
  • 0
  • 97

PRICE

6,962
11,316
17,033
24,701

PUBLISHED

1,528
2,360
6,744
24,701

PRODUCT TYPE

20,325
3,174
857
164
74
44
21
21
14
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Cough, Cold and Allergy (Hay Fever) Remedies in Kazakhstan Cough, Cold and Allergy (Hay Fever) Remedies in Kazakhstan - Product Thumbnail Image

Cough, Cold and Allergy (Hay Fever) Remedies in Kazakhstan

Towards the end of the review period, cough, cold and allergy (hay fever) remedies remained seasonal in Kazakhstan, with sales of cough and cold products increasing in autumn and winter. As the flu...

April 2013
FROM
Digestive Remedies in Kazakhstan Digestive Remedies in Kazakhstan - Product Thumbnail Image

Digestive Remedies in Kazakhstan

Towards the end of the review period, increasingly stressful lifestyles among consumers and longer working hours increased consumption of digestive remedies, as the first affected is usually the digestive...

April 2013
FROM
Analgesics in Kazakhstan Analgesics in Kazakhstan - Product Thumbnail Image

Analgesics in Kazakhstan

Towards the end of review period, analgesics was driven by the stressful and hectic lifestyle of many Kazakh consumers, particularly urban citizens, which supported the increasing demand for analgesics....

April 2013
FROM
Emergency Contraception in Sweden Emergency Contraception in Sweden - Product Thumbnail Image

Emergency Contraception in Sweden

Increased price competition contributed to a slowdown in value growth for Swedish emergency contraception in 2012. This is primarily due to new importers that entered the market and increased competition. Euromonitor...

April 2013
FROM
OTC Triptans in Sweden OTC Triptans in Sweden - Product Thumbnail Image

OTC Triptans in Sweden

The most likely customer of OTC triptans products in Sweden suffers from migraines but has not been diagnosed by a medical professional. The growing self-medication trend is therefore a key driver of...

April 2013
FROM
Pharmaceuticals in Spain: ISIC 2423 Pharmaceuticals in Spain: ISIC 2423 - Product Thumbnail Image

Pharmaceuticals in Spain: ISIC 2423

Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Pharmaceuticals market...

April 2013
FROM
Celldex's CDX-011 for GPNMB-postive breast cancer Celldex's CDX-011 for GPNMB-postive breast cancer - Product Thumbnail Image

Celldex's CDX-011 for GPNMB-postive breast cancer

Celldex's CDX-011 is in phase III for metastatic breast cancer that expresses GPNMB CDX-011 is an antibody-drug conjugate, meaning that a cytotoxic drug is linked to a monoclonal antibody The antibody...

April 2013
FROM

North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) – Forecast to 2017

'North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology,...

April 2013
FROM

Spain Pharmaceuticals and Healthcare Report Q2 2013

BMI View: The sharp drop in public pharmaceutical expenditure in Spain during the second half of 2012 warns of a continuing fall in spending on medicines in 2013. BMI notes that this does not bode well...

April 2013
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2013 Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2013 - Product Thumbnail Image

Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2013

Female Hypoactive Sexual Desire Disorder – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2013', provides an overview of...

April 2013
FROM
Percutaneous Coronary Intervention - Pipeline Review, H1 2013 Percutaneous Coronary Intervention - Pipeline Review, H1 2013 - Product Thumbnail Image

Percutaneous Coronary Intervention - Pipeline Review, H1 2013

Percutaneous Coronary Intervention – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Percutaneous Coronary Intervention - Pipeline Review, H1 2013', provides an overview of the indication’s...

April 2013
FROM
Cardiomyopathy - Pipeline Review, H1 2013 Cardiomyopathy - Pipeline Review, H1 2013 - Product Thumbnail Image

Cardiomyopathy - Pipeline Review, H1 2013

Cardiomyopathy – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Cardiomyopathy - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

April 2013
FROM
Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2013 Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2013 - Product Thumbnail Image

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2013

Post-Traumatic Stress Disorder (PTSD) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2013', provides an overview of the indication’s...

April 2013
FROM
Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2013 Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2013

Cutaneous T-Cell Lymphoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

April 2013
FROM
Ischemic Stroke - Pipeline Review, H1 2013 Ischemic Stroke - Pipeline Review, H1 2013 - Product Thumbnail Image

Ischemic Stroke - Pipeline Review, H1 2013

Ischemic Stroke – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Ischemic Stroke - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

April 2013
FROM

Iran Pharmaceuticals and Healthcare Report Q2 2013

BMI View: We expect the downward trajectory of pharmaceutical exports into Iran to continue throughout 2013, although essential medicines will still reach patients due to unmet demands and loopholes...

April 2013

Moldova Pharmaceuticals and Healthcare Report Q2 2013

BMI View: We continue to view Moldova as one of the least attractive emerging Europe markets for multinational companies. Per capita spending on medicines is low, on account of modest incomes, with...

April 2013

Sri Lanka Pharmaceuticals and Healthcare Report Q2 2013

BMI View: Economic growth will aid the development of Sri Lanka's pharmaceutical and healthcare sectors. We believe the affordability of, and fiscal contributions to, healthcare service provision will...

April 2013

Morocco Pharmaceuticals and Healthcare Report Q2 2013

BMI View: While Morocco’s pharmaceutical market is small in absolute terms, its forward growth trajectory is encouraging. Positive drivers include population growth and changing epidemiological profile,...

April 2013
Anesthetic Effect - Pipeline Review, H1 2013 Anesthetic Effect - Pipeline Review, H1 2013 - Product Thumbnail Image

Anesthetic Effect - Pipeline Review, H1 2013

Anesthetic Effect – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Anesthetic Effect - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

April 2013
FROM
Loading Indicator

Our Clients

Our clients' logos